Armis Biopharma announces FDA clearance for VeriFixx bone implant

Armis Biopharma announces FDA clearance for VeriFixx bone implant

FORT COLLINS -- Armis Biopharma, Inc. announced the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the VeriFixx Small Bone Implant for the fixation of osteotomies and... Read More

Monday November 23, 2020 0 comments Tags: Fort Collins, Armis Biopharma, VeriFixx, Ted Ziemann

Armis Biopharma announces $423K NIH grant

Armis Biopharma announces $423K NIH grant

FORT COLLINS -- Armis Biopharma, Inc. announced the National Institutes of Health (NIH) awarded the company a grant in the amount of$423,048to support development of a novel product for skin... Read More

Friday November 13, 2020 0 comments Tags: Fort Collins, Armis Biopharma, NIH, Ted Ziemann

Armis Biopharma announces launch of ArmiClenz disinfectant of surface bacteria, viruses

Armis Biopharma announces launch of ArmiClenz disinfectant of surface bacteria, viruses

FORT COLLINS -- Armis Biopharma Inc. announced the launch of a new surface disinfectant called ArmiClenz, which is registered with the EPA and is effective against most harmful bacteria and viruses... Read More

Wednesday June 3, 2020 0 comments Tags: Fort Collins, Armis Biopharma, ArmiClenz, Ted Ziemann

Armis Biopharma granted FDA designation for infectious disease product

Armis Biopharma granted FDA designation for infectious disease product

FORT COLLINS -- Armis Biopharma, Inc. , a late-stage clinical biopharmaceutical company with a growing pipeline of targeted anti-infective therapeutics designed to address the serious and... Read More

Thursday February 1, 2018 0 comments Tags: Fort Collins, Armis Biopharma, Mike Handley, Ximycin